Dr. Trc Lab Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 16-11-2024
- Paid Up Capital ₹ 0.20 M
as on 16-11-2024
- Company Age 4 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.45 Cr
as on 16-11-2024
- Revenue 75.22%
(FY 2023)
- Profit 17.17%
(FY 2023)
- Ebitda 127.23%
(FY 2023)
- Net Worth 80.02%
(FY 2023)
- Total Assets 68.34%
(FY 2023)
About Dr. Trc Lab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹2.45 Cr.
Tapan Chowdhury and Rina Tapan serve as directors at the Company.
- CIN/LLPIN
U24239DL2020PTC374001
- Company No.
374001
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Trc Lab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tapan Chowdhury  | Director | 02-Dec-2020 | Current |
| Rina Tapan | Director | 02-Dec-2020 | Current |
Financial Performance of Dr. Trc Lab.
Dr. Trc Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 75.22% increase. The company also saw a substantial improvement in profitability, with a 17.17% increase in profit. The company's net worth Soared by an impressive increase of 80.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Trc Lab?
Unlock access to Dr. Trc Lab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Karmaguru R & D Private LimitedActive 12 years 7 monthsTapan Chowdhury and Rina Tapan are mutual person
Dr. Trc Herbs Private LimitedActive 4 years 4 monthsTapan Chowdhury and Rina Tapan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jun 2024 | ₹1.20 Cr | Open |
Hdfc Bank Limited Creation Date: 11 Jul 2023 | ₹1.20 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Oct 2022 | ₹0.47 M | Open |
How Many Employees Work at Dr. Trc Lab?
Dr. Trc Lab has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Trc Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Trc Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
